Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	VRTXVertex Pharmaceuticals	GILDGilead Sciences	AMGNAmgen
Snapshot
Price	$466.79	$124.87	$344.72
Market cap	$115.02B	$153.66B	$182.21B
Valuation
P/E	26.3x	16.6x	23.5x
Forward P/E	24.7x	11.8x	17.9x
Growth
Revenue growth	10.1%	3.5%	9.1%
EPS growth	6.1%	55.5%	31.3%
Profitability
Net margin	35.5%	31.0%	21.0%
ROE	23.9%	42.2%	89.4%
Balance sheet & cash
Debt / equity	0.01x	1.1x	6.31x
Free cash flow yield	3.1%	5.2%	6.0%
Dividend yield	—	2.6%	2.9%
Verdict
Investment rating	Favorable· 67	Strong· 74	Favorable· 68

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	VRTXtoday $467	GILDtoday $125	AMGNtoday $345
2027	$371.52 – $544.89+17% CAGR	$145.62 – $213.58+71% CAGR	$339.39 – $497.77+44% CAGR
2028	$394.26 – $578.24+11% CAGR	$226.42 – $332.09+63% CAGR	$445.51 – $653.42+38% CAGR
2029	$418.38 – $613.63+10% CAGR	$352.07 – $516.37+61% CAGR	$584.82 – $857.74+36% CAGR
2030	$443.99 – $651.18+9% CAGR	$547.43 – $802.90+59% CAGR	$767.70 – $1,125.96+34% CAGR
2031	$471.16 – $691.04+8% CAGR	$851.20 – $1,248.43+58% CAGR	$1,007.76 – $1,478.04+34% CAGR
5-yr CAGR	0.2% – 8.2%	46.8% – 58.5%	23.9% – 33.8%